1666 related articles for article (PubMed ID: 23648430)
21. Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.
Umeda T; Maekawa S; Kimura T; Takashima A; Tomiyama T; Mori H
Acta Neuropathol; 2014 May; 127(5):685-98. PubMed ID: 24531886
[TBL] [Abstract][Full Text] [Related]
22. Peritoneal dialysis reduces amyloid-beta plasma levels in humans and attenuates Alzheimer-associated phenotypes in an APP/PS1 mouse model.
Jin WS; Shen LL; Bu XL; Zhang WW; Chen SH; Huang ZL; Xiong JX; Gao CY; Dong Z; He YN; Hu ZA; Zhou HD; Song W; Zhou XF; Wang YZ; Wang YJ
Acta Neuropathol; 2017 Aug; 134(2):207-220. PubMed ID: 28477083
[TBL] [Abstract][Full Text] [Related]
23. Amyloid-β pathology is attenuated by tauroursodeoxycholic acid treatment in APP/PS1 mice after disease onset.
Dionísio PA; Amaral JD; Ribeiro MF; Lo AC; D'Hooge R; Rodrigues CM
Neurobiol Aging; 2015 Jan; 36(1):228-40. PubMed ID: 25443293
[TBL] [Abstract][Full Text] [Related]
24. An early dysregulation of FAK and MEK/ERK signaling pathways precedes the β-amyloid deposition in the olfactory bulb of APP/PS1 mouse model of Alzheimer's disease.
Lachén-Montes M; González-Morales A; de Morentin XM; Pérez-Valderrama E; Ausín K; Zelaya MV; Serna A; Aso E; Ferrer I; Fernández-Irigoyen J; Santamaría E
J Proteomics; 2016 Oct; 148():149-58. PubMed ID: 27498392
[TBL] [Abstract][Full Text] [Related]
25. Combinatorial model of amyloid β and tau reveals synergy between amyloid deposits and tangle formation.
Koller EJ; Ibanez KR; Vo Q; McFarland KN; Gonzalez De La Cruz E; Zobel L; Williams T; Xu G; Ryu D; Patel P; Giasson BI; Prokop S; Chakrabarty P
Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12779. PubMed ID: 34825397
[TBL] [Abstract][Full Text] [Related]
26. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.
Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL
Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574
[TBL] [Abstract][Full Text] [Related]
27. Fuzhisan ameliorates Aβ production and tau phosphorylation in hippocampal of 11month old APP/PS1 transgenic mice: A Western blot study.
Zhang ZX; Zhao RP; Wang DS; Wang AN
Exp Gerontol; 2016 Nov; 84():88-95. PubMed ID: 27612601
[TBL] [Abstract][Full Text] [Related]
28. Partial Endothelial Nitric Oxide Synthase Deficiency Exacerbates Cognitive Deficit and Amyloid Pathology in the APPswe/PS1ΔE9 Mouse Model of Alzheimer's Disease.
Ahmed S; Jing Y; Mockett BG; Zhang H; Abraham WC; Liu P
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806318
[TBL] [Abstract][Full Text] [Related]
29. Sex Dimorphism Profile of Alzheimer's Disease-Type Pathologies in an APP/PS1 Mouse Model.
Jiao SS; Bu XL; Liu YH; Zhu C; Wang QH; Shen LL; Liu CH; Wang YR; Yao XQ; Wang YJ
Neurotox Res; 2016 Feb; 29(2):256-66. PubMed ID: 26707129
[TBL] [Abstract][Full Text] [Related]
30. Spatiotemporal activation of the C/EBPβ/δ-secretase axis regulates the pathogenesis of Alzheimer's disease.
Wang H; Liu X; Chen S; Ye K
Proc Natl Acad Sci U S A; 2018 Dec; 115(52):E12427-E12434. PubMed ID: 30530690
[TBL] [Abstract][Full Text] [Related]
31. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice.
Button EB; Boyce GK; Wilkinson A; Stukas S; Hayat A; Fan J; Wadsworth BJ; Robert J; Martens KM; Wellington CL
Alzheimers Res Ther; 2019 May; 11(1):44. PubMed ID: 31084613
[TBL] [Abstract][Full Text] [Related]
32. Reduction of beta-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease.
Paris D; Ganey NJ; Laporte V; Patel NS; Beaulieu-Abdelahad D; Bachmeier C; March A; Ait-Ghezala G; Mullan MJ
J Neuroinflammation; 2010 Mar; 7():17. PubMed ID: 20211007
[TBL] [Abstract][Full Text] [Related]
33. Opposing effects of progranulin deficiency on amyloid and tau pathologies via microglial TYROBP network.
Takahashi H; Klein ZA; Bhagat SM; Kaufman AC; Kostylev MA; Ikezu T; Strittmatter SM;
Acta Neuropathol; 2017 May; 133(5):785-807. PubMed ID: 28070672
[TBL] [Abstract][Full Text] [Related]
34. Benzo(a)pyrene exposure induced neuronal loss, plaque deposition, and cognitive decline in APP/PS1 mice.
Liu D; Zhao Y; Qi Y; Gao Y; Tu D; Wang Y; Gao HM; Zhou H
J Neuroinflammation; 2020 Aug; 17(1):258. PubMed ID: 32867800
[TBL] [Abstract][Full Text] [Related]
35. Expression of the plant viral protease NIa in the brain of a mouse model of Alzheimer's disease mitigates Aβ pathology and improves cognitive function.
Kim TK; Han HE; Kim H; Lee JE; Choi D; Park WJ; Han PL
Exp Mol Med; 2012 Dec; 44(12):740-8. PubMed ID: 23172351
[TBL] [Abstract][Full Text] [Related]
36. Multifocal Cerebral Microinfarcts Modulate Early Alzheimer's Disease Pathology in a Sex-Dependent Manner.
Lecordier S; Pons V; Rivest S; ElAli A
Front Immunol; 2021; 12():813536. PubMed ID: 35173711
[TBL] [Abstract][Full Text] [Related]
37. Cholesterol impairs autophagy-mediated clearance of amyloid beta while promoting its secretion.
Barbero-Camps E; Roca-Agujetas V; Bartolessis I; de Dios C; Fernández-Checa JC; Marí M; Morales A; Hartmann T; Colell A
Autophagy; 2018; 14(7):1129-1154. PubMed ID: 29862881
[TBL] [Abstract][Full Text] [Related]
38. Ube3a deficiency inhibits amyloid plaque formation in APPswe/PS1δE9 mouse model of Alzheimer's disease.
Singh BK; Vatsa N; Kumar V; Shekhar S; Sharma A; Jana NR
Hum Mol Genet; 2017 Oct; 26(20):4042-4054. PubMed ID: 29016862
[TBL] [Abstract][Full Text] [Related]
39. (S)-[
Alzghool OM; Rokka J; López-Picón FR; Snellman A; Helin JS; Okamura N; Solin O; Rinne JO; Haaparanta-Solin M
Neuropharmacology; 2021 Sep; 196():108676. PubMed ID: 34216585
[TBL] [Abstract][Full Text] [Related]
40. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]